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Background/Aims: We aimed to assess the effectiveness 
of self-expanding metal stent (SEMS) insertion by evaluating 
the learning curve in relation to the experience of an endos-
copist. Methods: We retrospectively analyzed the outcomes 
of 120 SEMS insertion procedures performed by one en-
doscopist in patients with malignant colorectal obstruction. 
We compared the technical and clinical success rates, com-
plication rates, and duration of the procedures by quartiles. 
Results: The mean age of the patients (76 men and 44 
women) was 64.6 years. The overall technical success rate 
was 95.0% (114/120), and the clinical success rate was 
90.0% (108/120). The median procedure duration was 16.2 
minutes (range, 3.4 to 96.5 minutes). From the first to the 
last quartile, the technical success rates were 90.0%, 96.7%, 
96.7%, and 96.7% (p=0.263), and the clinical success rates 
were 90.0%, 90.0%, 96.7%, and 83.3% (p=0.588), respec-
tively. Procedure-related complications were observed in 28 
patients (23.3%). The complication rates for SEMS insertion 
when patients were divided by quartiles were 26.7%, 23.3%, 
10.0%, and 33.3% (p=0.184), respectively. Moreover, the 
number of stents per procedure was 1.13, 1.03, 1.00, and 
1.00 (p=0.029), respectively. The median duration of SEMS 
insertion decreased significantly, 20.9 to 14.8 minutes after 
the first 30 procedures (p=0.005). Conclusions: An experi-
enced endoscopist was able to perform the SEMS insertion 
procedure easily and effectively after performing 30 SEMS 
insertions. (Gut Liver 2012;6:328-333)
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INTRODUCTION
Colorectal cancer is the third most common cancer in Korea 
and its incidence is rapidly increasing due to more western-
ized dietary habits.1,2 Approximately 20% of colorectal cancer 
patients are not eligible for curative surgery.3 Abdominal pain, 
nausea, vomiting, constipation, abdominal distension, and the 
inability to pass gas in patients with colorectal cancer can be 
signs of malignant colorectal obstruction, which can become 
a surgical emergency.4 Previously, surgical treatment in these 
cases was the only way to decompress the bowel. Since the  first 
case of palliative stent insertion in patients and cases of stent 
insertion as a bridge to surgery were reported, endoscopic stent-
ing with self-expanding metal stents (SEMS) has been widely 
used.5,6 Most studies on the effectiveness and safety of SEMS 
show that SEMS provide a safe single-stage surgical procedure 
that avoids colostomy in patients that received SEMS preopera-
tively. It also improves clinical outcomes and quality of life for 
patients undergoing palliative treatment.7,8 According to recent 
studies, the technical and clinical success rates of SEMS inser-
tion are reported to be above 90%.9,10 Therefore, the placement 
of SEMS for initial management of obstructive colorectal cancer 
is universally accepted.
Despite its general acceptance, the adequate level of training 
necessary for technical competence in SEMS insertion remains 
unknown. Detailing the learning curve for SEMS insertion could 
serve as a reference for gastroenterology specialists who would 
like to perform the procedure. Therefore, the aim of this study 
was to assess the effectiveness of SEMS insertion by evaluating 
the learning curve in relation to the experience of an endosco-
pist.
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MATERIALS AND METHODS
1. Patients
In this study, we analyzed the outcomes of 158 SEMS inser-
tion procedures performed by a single endoscopist (Cheon JH) in 
patients with malignant colorectal obstruction who were treated 
at Severance Hospital, Yonsei University College of Medicine, 
Seoul, Korea between March 2006 and December 2009. Our 
study was performed by a retrospective review of prospectively 
collected data on patient sex, age, cancer location, type of ob-
struction, purpose of SEMS insertion, type of stent, stent length, 
and number of stents. Exclusion criteria were as follows: 1) ex-
trinsic obstruction by other cancerous lesions (n=30); 2) a previ-
ous history of stent insertion at other hospitals (n=2); 3) benign 
stricture after a colon cancer operation (n=5); and 4) recurrence 
after a colon cancer operation (n=1). After excluding 38 pa-
tients, we compared the technical success rates, clinical success 
rates, complication rates, number of stents needed per procedure 
and procedure duration by quartiles.
This study was approved by the Institutional Review Board of 
Severance Hospital.
2. Definitions
The location of the cancer was categorized into two groups: 
right colon and left colon. The ascending colon and the trans-
verse colon were included as the right colon and the other areas 
were classified as the left colon. Technical failure was defined as 
failure to deploy a stent across the entire length of a colon stric-
ture. Clinical failure was defined as the absence of the resolu-
tion of obstructive symptoms (abdominal distension, vomiting, 
and abdominal pain) and the absence of gas and stool passage 
despite achieving technical success.11 Problems such as immedi-
ate migration, bleeding, and perforation were considered stent-
induced complications.12 Subtotal obstruction was defined as a 
state with narrow stool caliber or the ability to pass only small 
amounts of liquid stool or gas. Total obstruction was defined as 
decreased or absent bowel sounds or the inability to pass any 
stool or gas.7 Procedure time was calculated only after the colo-
noscope was advanced to the site of obstruction, then the time 
required to insert a guidewire and stent and to confirm correct 
positioning and expansion using fluoroscopy was included. 
3. Endoscopic technique
Before placing colonic stents, all patients underwent a com-
puted tomography (CT) scan and bowel preparation by glycerin 
and warm saline enema. We evaluated the CT scans to assess 
the extent of the tumor and the location, degree, and length of 
the obstruction. Stents were placed by one experienced colo-
noscopist (Cheon JH) from our hospital as previously described.1 
Before initiating SEMS insertion, the endoscopist had performed 
more than 1,000 colonoscopy procedures per year for several 
years but had no experience with endoscopic retrograde cholan-
giopancreatography. 
A flexible colonoscope (CF-H260AI; Olympus, Tokyo, Japan) 
was advanced to the site of the obstruction. A biliary guidewire 
(Jagwire; Boston Scientific, Natick, MA, USA) was inserted into 
the lumen of a catheter (ERCP-Catheter; MTW Endoskopie, 
Wesel, Germany), and the guidewire and the catheter were 
then advanced together beyond the obstruction. The distal and 
proximal ends of the stricture were confirmed under fluoro-
scopic guidance by injecting a water-soluble contrast agent 
(Gastrograffin; Bayer Schering Pharm., Seoul, Korea) through 
the catheter after removal of the guidewire. The compressed 
SEMS delivery system was then introduced through the work-
ing channel of the endoscope over the guidewire and passed 
beyond the stricture. Stent release and expansion progressed 
from the proximal to the distal portion under fluoroscopic and 
endoscopic control. Abdominal X-rays were obtained on the 
same day of the procedure, as well as the next day, to confirm 
correct positioning and expansion.
Stent type was selected according to the preference of the pa-
tient and the experience of the endoscopist. Stent length was se-
lected by allowing for at least an additional 2 cm to be exposed 
distal and proximal to the obstructing lesion. Four types of 
stents were used in our study: 1) covered Niti-s colonic covered 
stents (Taewoong Medical, Seoul, Korea); 2) newly developed, 
covered Comvi stents (Taewoong Medical); 3) uncovered Wall-
Flex colonic stents (Boston Scientific, Denver, CO, USA); and 4) 
uncovered Niti-s colonic D type stents (Taewoong Medical).13
4. Statistical analysis
Data were analyzed to identify the baseline patient character-
istics, sites of obstructing lesions, reasons for stenting, outcomes, 
procedure times, and complications. The data were expressed 
as the mean±SD, median (range), or no. (%) as appropriate. We 
compared categorical variables with the chi-square test and 
one-way ANOVA. Correlations between success rates, proce-
dure times, and level of experience were assessed using Tukey’s 
multiple comparison test and Dunn procedure. A p<0.05 on a 
two-tailed test was considered statistically significant. Statistical 




The baseline characteristics of the 120 patients are sum-
marized in Table 1. The mean age of the patients (76 men and 
44 women) was 64.6 years. The pathological diagnosis of all 
patients was adenocarcinoma. There were 103 (85.8%) patients 
with left-sided colonic obstruction, complete obstruction was 
present in 100 patients (83.3%) and partial obstruction was 
noted in 20 (16.7%). In terms of SEMS insertions, 45% (n=54) 
were performed for palliation and 55% (n=66) were performed 
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as a bridge to surgery. The type of stent was classified into cov-
ered (n=69, 57.5%) and uncovered stents (n=51, 42.5%). The 
median length of SEMS was 6 cm (range, 6 to 12 cm). Most 
patients (95%) underwent SEMS insertion when first diagnosed 
with colorectal cancer, whereas six patients underwent SEMS 
insertion during the follow-up period. The median period from 
the diagnosis of colorectal cancer to stent insertion in these six 
patients was 13.6 months (range, 3.1 to 33.0 months).
2. Stent insertion outcomes
The outcomes of stent insertion are shown in Table 2. Most 
patients (n=115, 95.8%) underwent the SEMS procedure with 
a single stent. Only five patients required two stents because 
of inadequate measurement of the length of the stricture (n=2) 
or technical failure (n=3). The overall technical success rate 
was 95.0% (114/120), and the clinical success rate was 90.0% 
(108/120). The median procedure duration was 16.2 minutes 
(range, 3.4 to 96.5 minutes). Re-intervention for SEMS inser-
tion was required in 25 patients (20.8%). The median interval 
between the initial stenting and the second attempt was 89 days 
(range, 1 to 947 days).
Procedure-related complications were observed in 28 patients 
(23.3%): obstruction in 11, hemorrhage in 4, stent migration 
in 11, and both hemorrhage and stent migration in 2 patients. 
There was no perforation, erosion/ulcer, or mortality. Among 
the patients with hemorrhage, there was no major bleeding 
necessitating blood transfusion. Stent migration occurred in 13 
patients, and one of these patients underwent emergent surgery, 
another was treated with re-positioning of a stent that had al-
ready been inserted, and the remaining patients had a new stent 
inserted. The median number of days between the insertion and 
migration was 47 days (range, 1 to 567 days). Stent obstruction 
was noted in 11 patients. One of them was transferred to an-
other hospital, another underwent emergent surgery, and three 
of the remaining patients underwent new stent insertion due to 
tumor ingrowth. The others recovered after removal of impacted 




Sex, male 76 (63.3)
Age, yr 64.6±13.2
Pathologic diagnosis
  Adenocarcinoma 120 (100)
  Differentiation
    Well differentiated 15 (12.5)
    Moderately differentiated 96 (80.0)
    Poorly differentiated 7 (5.8)
    Mucinous 2 (1.7)
Location
  Right colon 17 (14.2)
  Left colon 103 (85.8)
Type of obstruction
  Complete 100 (83.3)
  Partial 20 (16.7)
Purpose
  Palliation 54 (45.0)
  Bridge to surgery 66 (55.0)
Stents
  Type, covered/uncovered 69 (57.5)/51 (42.5)
  Length, cm 6 (6-12)
  No. 1/2 115 (95.8)/5 (4.2)
Data are presented as mean±SD or number (%). 
Table 2. Outcomes of Stent Insertion
Variable All patients (n=120) 1st Q (n=30) 2nd Q (n=30) 3rd Q (n=30) 4th Q (n=30) p-value
Location, Rt/Lt 17 (14.2)/103 (85.8) 5 (16.7)/25 (83.3) 2 (6.7)/28 (93.3) 3 (10.0)/27 (90.0) 7 (23.3)/23 (76.7) 0.414
Type of obstruction, complete/partial 20 (16.7)/100 (83.3) 7 (23.3)/23 (76.7) 2 (6.7)/28 (93.3) 3 (10.0)/27 (90.0) 8 (26.7)/22 (73.3) 0.663
Success rate, n (%)
  Technical success 114 (95.0) 27 (90.0) 29 (96.7) 29 (96.7) 29 (96.7) 0.263
  Clinical success 108 (90.0) 27 (90.0) 27 (90.0) 29 (96.7) 25 (83.3) 0.588
Complication, n (%) 28 (23.3) 8 (26.7) 7 (23.3) 3 (10.0) 10 (33.3) 0.184
No. 1/2 115 (95.8)/5 (4.2) 26 (86.7)/4 (13.3) 29 (96.7)/1 (3.3) 30 (100)/0 (0) 30 (100)/0 (0) 0.029
N° of stents per procedure 1.04 1.13 1.03 1.00 1.00 0.029
  T* a a, b b b
Procedure time, min 16.2 (3.4-96.5) 20.9 (7.5-96.5) 14.8 (6.0-59.4) 15.9 (3.4-36.4) 12.7 (5.6-33.9) 0.005
  T† a b b b
Data are presented as median (range) or number (%).
Q, quartile; Rt, right; Lt, left.
*The same letters indicate a nonsignificant difference between groups based on Tukey’s multiple comparison test; †The same letters indicate a 
nonsignificant difference between groups based on the multiple comparison test (Dunn procedure).
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stool. The median duration of obstruction was 3 days (range, 1 
to 947 days). Bleeding was noted in six patients a median of 2.7 
days (range, 1 to 4 days) after the procedure.
The technical and clinical success rates, complications, the 
number of stents used, and procedure time for each quartile are 
shown in Table 2 and Fig. 1. The location of obstruction site 
and the type of obstruction by quartile was not statistically dif-
ferent (p=0.414, p=0.663), respectively. From the first to the last 
quartile, the technical success rates were 90.0%, 96.7%, 96.7%, 
and 96.7% (p=0.263), and the clinical success rates were 90.0%, 
90.0%, 96.7%, and 83.3% (p=0.588), respectively. Complications 
occurred in 26.7%, 23.3%, 10.0%, and 33.3% (p=0.184) of the 
patients, and the number of stents per procedure was 1.13, 1.03, 
1.00, and 1.00 (p=0.029) by quartiles, respectively. The median 
procedure duration for SEMS insertion significantly decreased, 
20.9-14.8 minutes, after the first 30 procedures (p=0.005).
The technical success rate of the patients with right-sided 
colon obstruction and that of the patients with left-sided colon 
obstruction were similar (94.1% vs 95.2%, p=0.858), whereas 
the clinical success rate in the patients with right-sided colon 
obstruction was higher than that in the patients with left-sided 
colon obstruction (100% vs 88.4%, p<0.001). There was no sig-
nificant difference in procedure duration between patients with 
right-sided colon obstruction and patients with left-sided colon 
obstruction (24.5 minutes vs 19.1 minutes, p=0.118).
DISCUSSION
Malignant colorectal obstruction, partial colonic obstruc-
tion, and complete obstruction are observed in approximately 
20%, 10% to 20%, and 8% to 29% of patients with colorectal 
cancer, respectively.14-16 Complete colonic obstruction is a surgi-
cal emergency because intestinal perforation, sepsis, and death 
can occur.4 Nowadays, SEMS are effectively, safely, and widely 
used. In recent studies, both technical and clinical success rates 
of SEMS insertion were reported to be above 90%.9,10 Although 
SEMS insertion is widely used to relieve malignant colorectal 
obstruction, the optimal learning requirements for SEMS inser-
tion remain unknown. Therefore, we aimed to assess the effec-
tiveness of SEMS insertion by evaluating the learning curve in 
relation to the experience of an endoscopist.
According to recent studies, the technical and clinical success 
rates of SEMS insertion are reported to be above 90%.9,10 In this 
study, the overall technical success rate (95%) and the clinical 
Fig. 1. (A) Technical success rate. (B) Clinical success rate. (C) Procedure 
duration. (A) and (B) illustrate the learning curves for colorectal self-
expanding metal stents insertion, which reveal correlations between 
technical success rates (A), clinical success rates (B), and the endoscopist’s 
level of experience (p>0.05). (C) It demonstrates the correlation between 
procedure duration and level of experience. The median procedure dura-
tion decreased significantly after the first 30 procedures (p<0.05 with the 
multiple comparison test [Dunn procedure]).
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success rate (90%) were similar to those of previous studies. 
Furthermore, the technical and clinical success rates of the first 
quartile were both 90%, which indicates that stent insertion 
is not a difficult technique for experienced colonoscopists. 
Therefore, the learning curve based on the success rates of stent 
insertion per se might be less meaningful. However, the techni-
cal success rates had a tendency to be lower, although not sig-
nificantly different, in the first quartile than in the other periods 
(90% vs 96.7%). Further large-scale studies concerning the suc-
cess rate of SEMS insertion are needed to explain this tendency 
more precisely. The clinical success rate seems to be lower in 
the fourth quartile, though the difference was not statistically 
significant. The causes of failures were mostly (n=3/5, 60%) ob-
struction by stool impaction that resolved easily after removal 
of the stool. Sebastian et al.9 and Cho et al.17 reported that the 
technical success rate was lower in the group with proximal co-
lon obstruction than in the group with distal colon obstruction. 
However, we observed similar results between right-sided and 
left-sided colon obstructions (94.1% vs 95.2%, p=0.858). The 
procedure duration was similar between the patients with right-
sided colon obstruction and those with left-sided colon obstruc-
tion (24.5 minutes vs 19.1 minutes, p=0.118). In this study, the 
procedure duration was calculated after the colonoscope was 
advanced to the obstruction site. The time required to reach the 
obstruction site was not included. 
The complications of stent placement are perforation, stent 
migration, stent obstruction, and bleeding.18 Perforation is one 
of the most serious complications and occurred in 3.7% of pa-
tients in a pooled analysis.9 In our study, the overall complica-
tion rate was 23.3%, which is similar to that of another study.17 
The complication rates by quartile were not statistically different 
(p=0.184), which suggests that the effects of the learning curve 
on complications might be less significant in this study. Stent 
migration rates of 11% to 40% are reported, particularly with 
covered stents.9,19 We found no differences in the total compli-
cation rates between the covered and uncovered stent groups 
(17/69 [24.6%] vs 11/51 [21.6%]) (p=0.478), but the migration 
rate was higher in the covered stent group than in the uncov-
ered stent group (11/69 [15.9%] vs 2/51 [3.9%]) (p=0.041).
Interestingly, the first 30 cases of SEMS insertion required 
an average of 1.13 stents per procedure. However, in the third 
and fourth quartiles, all patients needed only one SEMS inser-
tion. Moreover, the insertion time decreased significantly, 20.9 
to 14.8 minutes, after 30 procedures (p=0.005). This indicates 
that endoscopists who are not familiar with the SEMS insertion 
procedure can perform the procedure effectively and safely after 
performing 30 SEMS insertions.
In this study, we collected the data in a prospective manner, 
and the learning curve was calculated using the results of SEMS 
insertion performed by one endoscopist. Bowel obstruction can 
also be caused by extrinsic compression or intraluminal inva-
sion from other abdominal malignancies, such as stomach or 
ovarian cancer.18 Other studies of the SEMS procedure involve 
both extrinsic and intrinsic causes of colon obstruction. How-
ever, this study only investigated malignant colorectal obstruc-
tion caused by colorectal cancer. In this study, we enrolled a 
larger number of patients compared to another study.20 We also 
analyzed complication rates and procedure durations by quar-
tiles in addition to technical and clinical success rates. Based on 
our results, the duration of the SEMS insertion procedure was 
dramatically reduced after the endoscopist had performed 30 
procedures. Similar to our results, Williams et al.20 reported the 
learning curve of colorectal stenting in 40 malignant colorectal 
obstruction patients, which revealed that at least 20 cases are 
required for an operator to be considered experienced based on 
the success rate and number of stents per procedure. 
Our study had several limitations. The data were collected 
prospectively but were analyzed retrospectively. The long-term 
follow-up of stent patency was not included in this study, so the 
comparison of stent patency of SEMS by quartiles needs further 
investigation. In conclusion, our study demonstrated that an 
experienced endoscopist can perform the SEMS insertion proce-
dure effectively and safely after performing 30 SEMS insertions.
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